| Laura R Kaufman, MD | |
|
9505 S Steele St, Tacoma, WA 98444-1858 | |
| (253) 597-6800 | |
| Not Available |
| Full Name | Laura R Kaufman |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 9505 S Steele St, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154472868 | NPI | - | NPPES |
| 8449027 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | MD00045515 (Washington) | Secondary |
| 207Q00000X | Family Medicine | MD00045515 (Washington) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Elective repair for abdominal aortic aneurysms (AAA) is on the rise, yet total AAA- related deaths continue to decline since the introduction of endovascular repair (EVAR), according to an ongoing, long-term research report from Beth Israel Deaconess Medical Center in Boston.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.
A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.
Sinobiopharma, Inc., an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wholly-owned subsidiary Dong Ying Pharmaceutical Co., Ltd., has signed an agreement with Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to co-develop, manufacture and commercialize Eplerenone, a therapeutic agent formulated to treat high blood pressure and vascular diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura R Kaufman, MD 9505 S Steele St, Tacoma, WA 98444-1858 Ph: (253) 597-6800 | Laura R Kaufman, MD 9505 S Steele St, Tacoma, WA 98444-1858 Ph: (253) 597-6800 |
News Archive
Elective repair for abdominal aortic aneurysms (AAA) is on the rise, yet total AAA- related deaths continue to decline since the introduction of endovascular repair (EVAR), according to an ongoing, long-term research report from Beth Israel Deaconess Medical Center in Boston.
Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, the p53 gene is thought to malfunction in more than 50% of cancerous tumors.
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.
A drug used for the treatment of sickle cell anemia in adults has now been shown to cause significant improvements in very young children with the disorder.
Sinobiopharma, Inc., an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wholly-owned subsidiary Dong Ying Pharmaceutical Co., Ltd., has signed an agreement with Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to co-develop, manufacture and commercialize Eplerenone, a therapeutic agent formulated to treat high blood pressure and vascular diseases.
› Verified 7 days ago
Dr. Kristina Siu Petsas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Mrs. Anne Garces Laporte, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Dr. Charles Gilbert Childers, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2624 S 38th St, Tacoma, WA 98409 Phone: 253-475-5908 Fax: 253-475-5958 | |
James M Roos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Loren B Betteridge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3733 S Thompson Ave, Tacoma, WA 98418 Phone: 253-472-4473 Fax: 253-474-3056 | |
Dr. Thuy-tien V Le, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 732 Broadway Ste 201, Tacoma, WA 98402 Phone: 702-871-8535 Fax: 941-499-0035 | |
Alexander K Lee, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-459-7785 |